Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EPS - Earnings per Share 2006-2021 | BMY

Bristol Myers Squibb annual and quarterly earnings per share history from 2006 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bristol Myers Squibb EPS for the quarter ending June 30, 2021 was $0.47, a 1275% decline year-over-year.
  • Bristol Myers Squibb EPS for the twelve months ending June 30, 2021 was $-2.25, a 703.57% increase year-over-year.
  • Bristol Myers Squibb 2020 annual EPS was $-3.99, a 298.51% decline from 2019.
  • Bristol Myers Squibb 2019 annual EPS was $2.01, a 33.22% decline from 2018.
  • Bristol Myers Squibb 2018 annual EPS was $3.01, a 393.44% increase from 2017.
  
Bristol Myers Squibb Annual EPS
2020 $-3.99
2019 $2.01
2018 $3.01
2017 $0.61
2016 $2.65
2015 $0.93
2014 $1.20
2013 $1.54
2012 $1.16
2011 $2.16
2010 $1.79
2009 $5.34
2008 $2.62
2007 $1.09
2006 $0.81
2005 $1.52
Bristol Myers Squibb Quarterly EPS
2021-06-30 $0.47
2021-03-31 $0.89
2020-12-31 $-4.43
2020-09-30 $0.82
2020-06-30 $-0.04
2020-03-31 $-0.34
2019-12-31 $-0.73
2019-09-30 $0.83
2019-06-30 $0.87
2019-03-31 $1.04
2018-12-31 $0.71
2018-09-30 $1.16
2018-06-30 $0.23
2018-03-31 $0.91
2017-12-31 $-1.40
2017-09-30 $0.51
2017-06-30 $0.56
2017-03-31 $0.94
2016-12-31 $0.53
2016-09-30 $0.72
2016-06-30 $0.69
2016-03-31 $0.71
2015-12-31 $-0.12
2015-09-30 $0.42
2015-06-30 $-0.08
2015-03-31 $0.71
2014-12-31 $0.01
2014-09-30 $0.43
2014-06-30 $0.20
2014-03-31 $0.56
2013-12-31 $0.43
2013-09-30 $0.42
2013-06-30 $0.32
2013-03-31 $0.37
2012-12-31 $0.57
2012-09-30 $-0.43
2012-06-30 $0.38
2012-03-31 $0.64
2011-12-31 $0.51
2011-09-30 $0.56
2011-06-30 $0.52
2011-03-31 $0.57
2010-12-31 $0.28
2010-09-30 $0.55
2010-06-30 $0.53
2010-03-31 $0.43
2009-12-31 $4.05
2009-09-30 $0.48
2009-06-30 $0.49
2009-03-31 $0.32
2008-12-31 $0.63
2008-09-30 $1.28
2008-06-30 $0.38
2008-03-31 $0.33
2007-12-31 $-0.05
2007-09-30 $0.43
2007-06-30 $0.36
2007-03-31 $0.35
2006-12-31 $-0.06
2006-09-30 $0.17
2006-06-30 $0.34
2006-03-31 $0.36
2005-12-31 $0.26
2005-09-30 $0.49
2005-06-30 $0.50
2005-03-31 $0.27
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $154.015B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $155.195B 309.21
Amgen (AMGN) United States $140.237B 15.01
CSL (CSLLY) Australia $99.509B 0.00
Gilead Sciences (GILD) United States $87.579B 8.46
BioNTech SE (BNTX) Germany $84.970B 61.61
Illumina (ILMN) United States $72.769B 104.93
Regeneron Pharmaceuticals (REGN) United States $62.489B 17.89
Vertex Pharmaceuticals (VRTX) United States $51.899B 20.17
Biogen (BIIB) United States $50.373B 13.83
BeiGene (BGNE) Cayman Islands $31.544B 0.00
Genmab (GNMSF) Denmark $30.486B 6.62
Genmab (GMAB) Denmark $30.385B 35.59
Seagen (SGEN) United States $28.780B 48.53
Horizon Therapeutics Public (HZNP) Ireland $22.423B 28.67
Alnylam Pharmaceuticals (ALNY) United States $21.018B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Bio-Techne Corp (TECH) United States $18.717B 98.42
Exact Sciences (EXAS) United States $17.919B 0.00
Incyte (INCY) United States $17.143B 40.81
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.250B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.024B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.237B 102.17
Zai Lab (ZLAB) China $14.001B 0.00
Novavax (NVAX) United States $13.972B 0.00
Repligen (RGEN) United States $13.675B 104.21
QIAGEN (QGEN) Netherlands $11.967B 20.27
Guardant Health (GH) United States $11.173B 0.00
CureVac (CVAC) Germany $10.194B 0.00
Intellia Therapeutics (NTLA) United States $9.459B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.252B 23.76
Mirati Therapeutics (MRTX) United States $8.399B 0.00
Fate Therapeutics (FATE) United States $7.828B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $7.729B 0.00
Acceleron Pharma (XLRN) United States $7.467B 0.00
Ascendis Pharma (ASND) Denmark $6.594B 0.00
Legend Biotech (LEGN) United States $6.484B 0.00
Denali Therapeutics (DNLI) United States $6.197B 222.30
I-Mab (IMAB) China $6.014B 0.00
Twist Bioscience (TWST) United States $5.819B 0.00
Beam Therapeutics (BEAM) United States $5.777B 0.00
Halozyme Therapeutics (HALO) United States $5.738B 31.48
Ultragenyx Pharmaceutical (RARE) United States $5.653B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.550B 19.89
Sarepta Therapeutics (SRPT) United States $5.508B 0.00
NeoGenomics (NEO) United States $5.447B 923.80
Exelixis (EXEL) United States $5.318B 84.85
Apellis Pharmaceuticals (APLS) United States $5.123B 0.00
Adaptive Biotechnologies (ADPT) United States $5.048B 0.00
Blueprint Medicines (BPMC) United States $5.037B 14.21
Arvinas (ARVN) United States $4.918B 0.00
Reata Pharmaceuticals (RETA) United States $4.659B 0.00
Vir Biotechnology (VIR) United States $4.538B 0.00
Alkermes (ALKS) Ireland $4.495B 132.67
AbCellera Biologics (ABCL) $4.267B 0.00
SpringWorks Therapeutics (SWTX) United States $4.201B 0.00
Certara (CERT) United States $4.025B 0.00
Galapagos (GLPG) Belgium $3.997B 0.00
Arena Pharmaceuticals (ARNA) United States $3.668B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.465B 0.00
Emergent Biosolutions (EBS) United States $3.404B 8.21
Berkeley Lights (BLI) United States $2.984B 0.00
Editas Medicine (EDIT) United States $2.856B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.838B 0.00
Intra-Cellular Therapies (ITCI) United States $2.806B 0.00
Myriad Genetics (MYGN) United States $2.715B 0.00
Kymera Therapeutics (KYMR) United States $2.702B 0.00
Heska (HSKA) United States $2.651B 518.90
BAVARIAN NORDIC (BVNRY) Denmark $2.623B 0.00
Insmed (INSM) United States $2.488B 0.00
Amicus Therapeutics (FOLD) United States $2.482B 0.00
ALX Oncology Holdings (ALXO) United States $2.475B 0.00
Sorrento Therapeutics (SRNE) United States $2.437B 0.00
Vericel (VCEL) United States $2.398B 646.50
Prothena (PRTA) Ireland $2.390B 0.00
Atea Pharmaceuticals (AVIR) United States $2.303B 0.00
Protagonist Therapeutics (PTGX) United States $2.165B 0.00
Revance Therapeutics (RVNC) United States $2.157B 0.00
Arcus Biosciences (RCUS) United States $2.131B 0.00
Instil Bio (TIL) United States $2.102B 0.00
Celldex Therapeutics (CLDX) United States $2.086B 0.00
Cytokinetics (CYTK) United States $2.068B 0.00
Alector (ALEC) United States $2.057B 0.00
C4 Therapeutics (CCCC) United States $1.984B 0.00
Morphic Holding (MORF) United States $1.941B 0.00
Myovant Sciences (MYOV) United Kingdom $1.904B 0.00
Seer (SEER) $1.902B 0.00
Ligand Pharmaceuticals (LGND) United States $1.849B 27.08
Inovio Pharmaceuticals (INO) United States $1.803B 0.00
MorphoSys AG (MOR) Germany $1.801B 0.00
Castle Biosciences (CSTL) United States $1.763B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.711B 0.00
Amarin (AMRN) Ireland $1.698B 0.00
Bluebird Bio (BLUE) United States $1.694B 0.00
Global Blood Therapeutics (GBT) United States $1.674B 0.00
Bionano Genomics (BNGO) United States $1.651B 0.00
PHARMA MAR SA (PHMMF) Spain $1.585B 0.00
Avid Bioservices (CDMO) United States $1.578B 645.50
ADC Therapeutics SA (ADCT) Switzerland $1.554B 0.00
NGM Biopharmaceuticals (NGM) United States $1.552B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.546B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.533B 0.00
Nurix Therapeutics (NRIX) United States $1.493B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.491B 0.00
Zymeworks (ZYME) Canada $1.475B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.461B 0.00
MiMedx (MDXG) United States $1.405B 0.00
Ocugen (OCGN) United States $1.398B 0.00
Codexis (CDXS) United States $1.394B 0.00
Sangamo Therapeutics (SGMO) United States $1.378B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
REGENXBIO (RGNX) United States $1.362B 0.00
UniQure (QURE) Netherlands $1.353B 4.60
BioAtla (BCAB) United States $1.347B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.341B 0.00
Zealand Pharma (ZEAL) Denmark $1.328B 0.00
Genetron Holdings (GTH) China $1.256B 0.00
Repare Therapeutics (RPTX) Canada $1.240B 0.00
Agenus (AGEN) United States $1.212B 0.00
Precigen (PGEN) United States $1.129B 0.00
Dynavax Technologies (DVAX) United States $1.116B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.109B 0.00
Nkarta (NKTX) United States $1.091B 0.00
Scholar Rock Holding (SRRK) United States $1.042B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Inhibrx (INBX) United States $1.033B 0.00
Coherus BioSciences (CHRS) United States $1.001B 0.00
MannKind (MNKD) United States $0.994B 0.00
Northwest Biotherapeutics (NWBO) United States $0.984B 0.00
Mesoblast (MESO) Australia $0.961B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.941B 29.17
KaloBios Pharmaceuticals (HGEN) United States $0.938B 0.00
Travere Therapeutics (TVTX) United States $0.860B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Prometheus Biosciences (RXDX) United States $0.841B 0.00
Sutro Biopharma (STRO) United States $0.825B 0.00
Keros Therapeutics (KROS) United States $0.810B 0.00
IDEAYA Biosciences (IDYA) United States $0.807B 0.00
VBI Vaccines (VBIV) United States $0.794B 0.00
RAPT THERAPTICS (RAPT) United States $0.778B 0.00
Kadmon Holdings (KDMN) United States $0.777B 0.00
Pliant Therapeutics (PLRX) United States $0.775B 0.00
Mersana Therapeutics (MRSN) United States $0.759B 0.00
Pharming Group (PHAR) Netherlands $0.730B 0.00
Adagene (ADAG) China $0.728B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Avidity Biosciences (RNA) United States $0.716B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.714B 0.00
G1 THERAPEUTICS (GTHX) United States $0.708B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.706B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.695B 0.00
Merus (MRUS) Netherlands $0.694B 0.00
SESEN BIO, INC (SESN) United States $0.691B 0.00
Affimed (AFMD) Germany $0.677B 0.00
Epizyme (EPZM) United States $0.669B 0.00
AnaptysBio (ANAB) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Curis (CRIS) United States $0.640B 0.00
Seres Therapeutics (MCRB) United States $0.638B 0.00
Cellectis S.A (CLLS) France $0.619B 0.00
MeiraGTx Holdings (MGTX) United States $0.617B 0.00
Akoya Biosciences (AKYA) United States $0.615B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.603B 0.00
ChromaDex (CDXC) United States $0.593B 0.00
Anika Therapeutics (ANIK) United States $0.588B 0.00
Cara Therapeutics (CARA) United States $0.584B 50.74
Precision BioSciences (DTIL) United States $0.563B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.560B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.552B 0.00
ALBIREO PHARMA (ALBO) United States $0.547B 0.00
DBV Technologies S.A (DBVT) France $0.547B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.541B 0.00
VistaGen Therapeutics (VTGN) United States $0.530B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.521B 9.50
Verastem (VSTM) United States $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.518B 0.00
Vaccitech (VACC) United Kingdom $0.517B 0.00
Clene (CLNN) United States $0.508B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
Inventiva S.A (IVA) France $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.494B 0.00
XBiotech (XBIT) United States $0.484B 0.00
Cybin (CLXPF) Canada $0.456B 0.00
Compugen (CGEN) Israel $0.451B 0.00
Bolt Biotherapeutics (BOLT) United States $0.426B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.421B 11.61
Selecta Biosciences (SELB) United States $0.419B 0.00
Kindred Biosciences (KIN) United States $0.419B 0.00
Oncobiologics (OTLK) United States $0.418B 0.00
Athenex (ATNX) United States $0.415B 0.00
Spero Therapeutics (SPRO) United States $0.412B 0.00
Forte Biosciences (FBRX) United States $0.405B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Codiak BioSciences (CDAK) United States $0.393B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.391B 0.00
Geron (GERN) United States $0.389B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 15.60
BeyondSpring (BYSI) United States $0.377B 0.00
CytomX Therapeutics (CTMX) United States $0.373B 0.00
Amryt Pharma (AMYT) United Kingdom $0.370B 0.00
XOMA (XOMA) United States $0.367B 171.32
Cel-Sci (CVM) United States $0.355B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.345B 0.00
SQZ Biotechnologies (SQZ) United States $0.338B 0.00
AquaBounty Technologies (AQB) United States $0.337B 0.00
Athersys (ATHX) United States $0.335B 0.00
Theratechnologies (THTX) Canada $0.332B 0.00
Gritstone Bio (GRTS) United States $0.330B 0.00
UROGEN PHARMA (URGN) United States $0.328B 0.00
Cue Biopharma (CUE) United States $0.328B 0.00
Angion Biomedica (ANGN) United States $0.325B 0.00
Opthea (OPT) Australia $0.316B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.307B 0.00
Fortress Biotech (FBIO) United States $0.306B 0.00
Clearside Biomedical (CLSD) United States $0.295B 0.00
Puma Biotechnology (PBYI) United States $0.295B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.291B 0.00
Neoleukin Therapeutics (NLTX) United States $0.288B 0.00
Frequency Therapeutics (FREQ) United States $0.284B 0.00
Syros Pharmaceuticals (SYRS) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.280B 0.00
Prima BioMed (IMMP) Australia $0.273B 0.00
IBio (IBIO) United States $0.268B 0.00
Innate Pharma S.A (IPHA) France $0.266B 0.00
Arbutus Biopharma (ABUS) United States $0.265B 0.00
Talis Biomedical (TLIS) United States $0.260B 0.00
Cerecor (CERC) United States $0.258B 0.00
Kamada (KMDA) Israel $0.257B 17.51
OVID THERAPEUTC (OVID) United States $0.251B 2.47
Paratek Pharmaceuticals (PRTK) United States $0.251B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.246B 0.00
Kaleido Biosciences (KLDO) $0.241B 0.00
Cogent Biosciences (COGT) United States $0.240B 0.00
Fulcrum Therapeutics (FULC) United States $0.238B 0.00
Chiasma (CHMA) United States $0.234B 0.00
INmune Bio (INMB) United States $0.233B 0.00
Adicet Bio (ACET) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.230B 0.00
Bellus Health (BLU) Canada $0.230B 0.00
CorMedix Inc (CRMD) United States $0.225B 0.00
Trevena (TRVN) United States $0.224B 0.00
Kala Pharmaceuticals (KALA) United States $0.223B 0.00
OSMOTICA PHARM (OSMT) United States $0.222B 0.00
Checkpoint Therapeutics (CKPT) United States $0.204B 0.00
ADMA Biologics Inc (ADMA) United States $0.203B 0.00
NextCure (NXTC) United States $0.197B 0.00
TELA Bio (TELA) United States $0.197B 0.00
HOOKIPA Pharma (HOOK) United States $0.194B 0.00
Cardiff Oncology (CRDF) United States $0.193B 0.00
Beyond Air (XAIR) United States $0.183B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.179B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Biofrontera AG (BFRA) Germany $0.178B 0.00
VolitionRX (VNRX) United States $0.175B 0.00
Aptinyx (APTX) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Erytech Pharma SA (ERYP) France $0.168B 0.00
Seelos Therapeutics (SEEL) United States $0.164B 0.00
Strongbridge Biopharma (SBBP) United States $0.160B 0.00
PHASEBIO PHARMA (PHAS) United States $0.160B 0.00
Enzo Biochem (ENZ) United States $0.159B 47.00
VTv Therapeutics (VTVT) United States $0.158B 0.00
Applied Genetic Technologies (AGTC) United States $0.155B 0.00
Synlogic (SYBX) United States $0.152B 0.00
ObsEva SA (OBSV) Switzerland $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
X4 Pharmaceuticals (XFOR) United States $0.140B 0.00
LogicBio Therapeutics (LOGC) United States $0.137B 0.00
Purple Biotech (PPBT) Israel $0.137B 0.00
Galena Biopharma (SLS) United States $0.137B 0.00
Exicure (XCUR) United States $0.134B 0.00
Cyclerion Therapeutics (CYCN) United States $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.127B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.127B 0.00
Entera Bio (ENTX) Israel $0.125B 0.00
Abeona Therapeutics (ABEO) United States $0.125B 0.00
Voyager Therapeutics (VYGR) United States $0.124B 3.19
Orgenesis (ORGS) United States $0.123B 250.50
Viridian Therapeutics (VRDN) United States $0.122B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.118B 0.00
Novogen (KZIA) Australia $0.115B 0.00
Longeveron (LGVN) United States $0.108B 0.00
Eyenovia (EYEN) United States $0.108B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.107B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.105B 0.00
Pluristem Therapeutics (PSTI) Israel $0.104B 0.00
Yumanity Therapeutics (YMTX) United States $0.102B 0.00
Vascular Biogenics (VBLT) Israel $0.101B 0.00
Aytu BioPharma (AYTU) United States $0.098B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.096B 0.00
Celsion (CLSN) United States $0.093B 0.00
Dyadic (DYAI) United States $0.092B 0.00
Leap Therapeutics (LPTX) United States $0.091B 0.00
Liminal BioSciences (LMNL) Canada $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
AEterna Zentaris (AEZS) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Evofem Biosciences (EVFM) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.081B 0.00
Aptevo Therapeutics (APVO) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.079B 0.00
Vyant Bio (VYNT) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
AIkido Pharma (AIKI) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
ATyr Pharma (LIFE) United States $0.073B 0.00
Protalix BioTherapeutics (PLX) Israel $0.072B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Celyad SA (CYAD) Belgium $0.066B 0.00
Lumos Pharma (LUMO) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
Advaxis (ADXS) United States $0.063B 0.00
DiaMedica Therapeutics (DMAC) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
BioCardia (BCDA) United States $0.059B 0.00
Idera Pharmaceuticals (IDRA) United States $0.056B 0.00
Cytocom (CBLI) United States $0.055B 0.00
Windtree Therapeutics (WINT) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
TRACON Pharmaceuticals (TCON) United States $0.053B 0.00
Cyclo Therapeutics (CYTH) United States $0.053B 0.00
ARIDIS PHARMACT (ARDS) United States $0.050B 0.00
AnPac Bio-Medical Science (ANPC) China $0.049B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.046B 0.00
Enveric Biosciences (ENVB) United States $0.041B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Timber Pharmaceuticals (TMBR) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.89
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Benitec Biopharma (BNTC) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
ZIVO Bioscience (ZIVO) United States $0.018B 0.00
Palisade Bio (PALI) United States $0.008B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00